The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer (Q41785872)
Jump to navigation
Jump to search
scientific article published on 24 September 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer |
scientific article published on 24 September 2013 |
Statements
1 reference
The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer (English)
1 reference
1 reference
1 reference
Silvia C Formenti
1 reference
24 September 2013
1 reference
Identifiers
1 reference